Horizon Oncology Center
- Research works
- 30 ▼ 60% vs 2013–17
- Citations
- 503 16.9 per fractional work
- Top-10% rate
- 9.9% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: Horizon Oncology Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.0×. Every wedge is a field page.
Who are the top researchers at Horizon Oncology Center?
Ranked on the composite score, T. M. Niebauer and Wael A. Harb lead among researchers whose main affiliation is Horizon Oncology Center.
- 1 T. M. Niebauer United States · #582,174 worldwide 53 citations · 16 works
- 2 Wael A. Harb United States · #701,088 worldwide 58 citations · 29 works
Which keywords describe research at Horizon Oncology Center?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Targeted Therapy, Immunotherapy, Clinical Trials, Breast Cancer, Cancer Immunotherapy, Prognostic Factors and Tumor Microenvironment.
- Trastuzumab
- Medical Research
- Chimeric Antigen Receptor
- Rituximab
- Metastatic
- Geodetic Measurements
- PD-1 and PD-L1
- Tumor Regression
- Metastatic Breast Cancer
- EGFR Mutations
- Tumor Microenvironment
- Cancer Immunotherapy
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- Immunotherapy
- Breast Cancer
- Prognostic Factors
- ALK Inhibitors
- Lymphoma
- Cancer
- Immune Checkpoint Blockade
- Biomarkers
- Immunity
- PET Imaging
- CAR T Cells
- HER2
- Physician-Scientist
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 28 words, with their numbers
- Chemotherapy4▲ 16×11 topics
- Targeted Therapy3▲ 50×5 topics
- Immunotherapy3▲ 15×9 topics
- Clinical Trials2▲ 13×3 topics
- Breast Cancer2▲ 26×3 topics
- Cancer Immunotherapy2▲ 50×3 topics
- Prognostic Factors2▲ 14×5 topics
- Tumor Microenvironment2▲ 17×4 topics
- ALK Inhibitors2▲ 96×1 topic
- EGFR Mutations2▲ 96×1 topic
- Lymphoma2▲ 37×2 topics
- Metastatic Breast Cancer2▲ 83×2 topics
- Cancer2▲ 3.5×9 topics
- Tumor Regression2▲ 59×2 topics
- Immune Checkpoint Blockade1▲ 77×1 topic
- PD-1 and PD-L11▲ 77×1 topic
- Biomarkers1▲ 5.9×3 topics
- Geodetic Measurements1▲ 29×2 topics
- Immunity1▲ 11×3 topics
- Metastatic1▲ 57×2 topics
- PET Imaging1▲ 17×3 topics
- Rituximab1▲ 24×2 topics
- CAR T Cells1▲ 81×1 topic
- Chimeric Antigen Receptor1▲ 81×1 topic
- HER21▲ 114×1 topic
- Medical Research1▲ 115×1 topic
- Physician-Scientist1▲ 115×1 topic
- Trastuzumab1▲ 81×1 topic
Which research topics does Horizon Oncology Center publish most on?
By volume in 2022–2025: Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Dermatologic Treatments and Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immunotherapy and Immune Responses Immunology 0 works
- 2 CAR-T cell therapy research Oncology 0 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 4 Dermatologic Treatments and Research Dermatology 0 works
- 5 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
- 6 Hair Growth and Disorders Urology 0 works
- 7 Animal Nutrition and Physiology Animal Science and Zoology 0 works
- 8 Antioxidant Activity and Oxidative Stress Biochemistry 0 works
- 9 Oral Health Pathology and Treatment Periodontics 0 works
- 10 HER2/EGFR in Cancer Research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Horizon Oncology Center's research output changed?
Output in 2018–2022 was 60% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lafayette
- Lafayette School Corporation
- Cook Biotech (United States)
- HemoCleanse (United States)
- Ash Access Technology (United States)
- Tippecanoe County Public Library
- Indiana Space Grant Consortium
- SpeechVive (United States)
- Spensa Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.